|

|

NATIONAL CENTER FOR POLICY ANALYSIS
/
/
/
/
| In Search of Vaccines |
|
|
Why are there nationwide shortages of vaccines for children's diseases -- in a rich country that spends 13 percent of its gross domestic product on health care? Hint: The government cut their prices.
- Health care professionals are scrambling to find vaccines for such serious childhood diseases as diphtheria, whooping cough, measles, mumps and chicken pox.
- Federal and state governments combined buy more than half of the country's childhood vaccines.
- With all that purchasing clout, governments are able to obtain vaccines for diphtheria, tetanus and whooping cough at 60 percent of the market price; 55 percent for vaccines covering measles, mumps and rubella; and as little as 38 percent for some other vaccines.
- As a result, the number of vaccine manufacturers has dropped from 37 in the mid-1960s to just four major manufacturers today -- with only two headquartered in the United States.
In the 1970s and 1980s, the open-ended threat of tort suits scared pharmaceutical companies out of vaccine manufacture.
Congress responded in 1986 by setting up a system of no-fault compensation for people injured by childhood vaccines. Then lawmakers put the government more deeply in the market.
Now, in 15 states, the government provides free vaccines to every child -- no matter how wealthy or well-insured the parents are.
With profit margins slim, the few remaining manufacturers maintain just enough production capability and inventory to meet demand -- if all goes well. But in a process as complex as manufacturing vaccines, it rarely does -- thus, shortages.
Source: Ira Carnahan, "Duh!" Forbes, March 18, 2002.
For text http://www.forbes.com/forbes/2002/0318/050.html
For more on Drug Price Issues http://www.ncpa.org/iss/hea
|
12770 Coit Rd., Suite 800 - Dallas, TX 75251-1339 - 972/386-6272 - Fax 972/386-0924
601 Pennsylvania Ave. NW, Suite 900 South Building - Washington, DC 20004 - 202/220-3082 - Fax 202/220-3096
Copyright © 2002 National Center for Policy Analysis - All rights reserved.
|
|